CatalystEarnings

$VRTX. VERTEX PHARMACEUTICALS

VRTX

$530.76

-4.05%

What changed

FQ3 FY2026 (ends Sep) | reported Nov 02: - Revenue: $3.44B - Adj EPS: $4.76 vs $4.75 🟢 Guidance (company): - FY2026 guidance, fiscal year ending Dec 31 revenue: $13.10B-$13.20B

Why it matters

FQ3 FY2026 (ends Sep) | reported Nov 02:

Sources

sec